Skip to main content
FUNR logo

Funr (FUNR) Stock Price & Analysis

FUNR — price $0.24 (0.00%), as of the Nov 18, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$0.24 $0.00 (0.00%)

Funr · FUNR · Communication Services · Electronic Gaming & Multimedia

Research dated 2026-09-13: FUNR trades on the OTC market as the shell of International Precious Metals Corp, renamed from Cuba Beverage Company with stated focus on BioTech, MedTech, and artificial intelligence intellectual property licensing. The central question is whether this rebrand reflects actual development or remains a dormant corporate vehicle.

Price as of Nov 18, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • DKI · DarkIris Inc. Class A Ordinary Shares · 18 /100
  • TTWO · Take-Two Interactive Software, Inc. · 33 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.24
Change on the day0.00%
52-week range$0.01–$20000.00
Shares traded on the day70

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $0.020, high $7.00, latest $0.240. $7.00 $0.020 high $7.00 Oct 17, 2025 Nov 18, 2026 · $0.240 $7.00Oct 17, 2025$5.00Oct 31, 2025$2.00Nov 14, 2025$3.00Nov 28, 2025$1.00Dec 12, 2025$3.00Dec 26, 2025$3.00Jan 9, 2026$3.00Jan 23, 2026$2.00Feb 6, 2026$2.00Feb 20, 2026$2.00Mar 6, 2026$4.00Mar 20, 2026$3.00Apr 2, 2026$3.00Apr 17, 2026$3.00May 1, 2026$3.00May 15, 2026$2.00May 29, 2026$1.00Jun 12, 2026$2.00Jun 26, 2026$2.00Jul 10, 2026$2.00Jul 24, 2026$2.00Aug 7, 2026$2.00Aug 21, 2026$0.160Sep 4, 2026$0.230Sep 18, 2026$1.00Oct 2, 2026$0.226Oct 16, 2026$0.240Oct 30, 2026$0.240Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Funr (FUNR): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 7, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Overvalued
Profit Margin Strong
Revenue Growth Negative
Debt/Equity Strong
ROE Negative
Gross Margin Negative

Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Apr 29, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Funr (FUNR), and what does it report?

Short answer · as of

The company claims to focus on BioTech, MedTech, Statistical Data Gathering, and artificial intelligence combined with intellectual property and brand licensing across multiple FUNR divisions.

The reporting structure reveals almost no sales activity. A filing gap spanning decades makes it impossible to confirm whether the renamed entity conducts actual research, development, or commercialization.

2 · Latest results

What do the latest results show for Funr (FUNR)?

Short answer · as of

The most recent reported quarter, Q4 FY2025, carried revenue of $6,220.

The most recent quarterly results show revenue at minimal levels with consistent operating losses. Cash and short-term investments record as absent across all reported periods. The company carries minimal debt, suggesting neither meaningful cash generation nor significant creditor obligations, only ongoing quarterly depletion from operating expenses.

Quarterly income statement — 1 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2025$6,220$21,219$0.00 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Funr (FUNR)?

Short answer · as of

The distress and quality screens read Piotroski F 0.

The absence of material debt means the company faces no immediate solvency pressure from creditors. Conversely, the lack of liquid resources combined with consistent quarterly losses implies the shell is consuming its remaining capital structure. The fundamental risk is that a dormant vehicle with aspirational business claims but no SEC filings may never transition to legitimate operations, leaving shareholders with a trading shell backed by no substantive business.

4 · What to check next?

What should you watch next at Funr (FUNR)?

The critical diagnostic is whether the company files material periodic updates in coming periods. A resumption of SEC filings detailing actual BioTech or MedTech research, product development, or partnership agreements would signal genuine operational change. Until then, the filing gap remains the clearest indicator that the corporate rebrand reflects aspiration rather than execution.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • No insider Form 4 transaction falls inside the window this page reads.
  • Fewer than two score snapshots exist, so no score trend is shown.

Checked against the records this page reads, on the dates shown above.

5 · Score methodology

How is Funr scored?

Meaningful comparison to operating BioTech or MedTech enterprises is not possible, as FUNR shows no revenue, no disclosed product development, no analyst coverage, and no scoring methodology application. It is functionally a dormant shell with an aspirational rebrand, not a development-stage competitor in biotech or medical technology. The absence of analyst interest and the quality gate assessment reflect the company's lack of substantive business signals.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Fund.com Inc. (FNDM) Named competitor$1.25 Nov 18, 2026$7.91M— Model unavailable
DarkIris Inc. Class A Ordinary Shares (DKI) Same industry, near in market value$1.14 Nov 18, 2026—— 5-pillar · not comparable
Take-Two Interactive Software, Inc. (TTWO) Same industry, near in market value$216.61 Nov 18, 2026$40.6B— 5-pillar · not comparable

The comparison model is unavailable. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Communication Services stocks

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held FUNR in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported FUNR in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What Investors Ask About Funr (FUNR) — Communication Services

The last question is answered from this page's own dated data, not from the research.

Has FUNR filed any substantive disclosure since the rebrand?

No SEC filings appear in the company's feed after the rebranding. The gap from earlier decades through to the present remains unbroken by any periodic disclosure of development activity or business operations.

Does FUNR hold any cash or liquid resources?

The company reports no cash or short-term investments across all periods in the filing record. Quarterly operating losses suggest ongoing consumption of whatever capital structure the entity maintains, leaving it with minimal ability to fund new initiatives.

Who is the chief officer of FUNR?

Alex Procopio serves as Chairman and Chief Executive Officer. Beyond the named title, no public compensation data, biographical detail, or insider transaction history appears in available records.

What would confirm FUNR is developing the BioTech business it describes?

A resumption of SEC periodic filings with substantive product descriptions, development milestones, partnership agreements, or patent activity would be the primary signal of real progress. The absence of filings is the clearest indication that the stated business claims remain unrealized.

What is the FUNR stock price today?

The last price recorded for FUNR, with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 9 figures on this page — 8 from Financial Modeling Prep (FMP) and 1 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Ticker / exchange; Legal name; Business description; Listed since
  • 1. What is Funr (FUNR), and what does it report?: Business description; Most recent periodic reports; What the sources do not tell us; Quarterly income statement (USD thousands)
  • 2. What do the latest results show for Funr (FUNR)?: Quarterly income statement (USD thousands); Cash and short-term investments over time (USD millions); Cash, investments and debt; Operating cash flow by quarter (USD millions)
  • 3. What are the financial strengths and risks for Funr (FUNR)?: Cash and investment components; Operating cash flow by quarter (USD millions); Trailing twelve-month ratio set; Cash against market value
  • 4. What should you watch next at Funr (FUNR)?: Most recent periodic reports; What the sources do not tell us; Business description
  • 5. How is Funr scored?: What the sources do not tell us; Page quality gate score; Quarterly income statement (USD thousands); Business description
  • FAQ: Has FUNR filed any substantive disclosure since the rebrand?: Most recent periodic reports; What the sources do not tell us; Business description
  • FAQ: Does FUNR hold any cash or liquid resources?: Cash and short-term investments over time (USD millions); Operating cash flow by quarter (USD millions); Cash and investment components
  • FAQ: Who is the chief officer of FUNR?: Named officers; What the sources do not tell us; Legal name
  • FAQ: What would confirm FUNR is developing the BioTech business it describes?: Most recent periodic reports; Business description; What the sources do not tell us
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.